According to the first reported LeuT structure 1 (PDB 2A65), one leucine substrate is bound in an occluded, centrally located binding site, termed the primary substrate (S1) binding site, next to two Na + ions. Subsequent LeuT structures revealed other amino acid substrates in place of leucine in the S1 site, with an essentially identical protein structure 2 . Although density in an extracellular vestibule ~11 Å above the leucine-bound S1 site was originally interpreted as water molecules 2 (see Fig. S7 in ref. 2), this structure was refined to show a molecule of n-octyl-β-D-glucopyranoside (octylglucoside) detergent in this position (PDB 3F3E, with an all-Cα r.m.s. deviation of 0.17 against PDB 2A65) 2 , in agreement with another structure that resolved octylglucoside in this site (PDB 3GJC) 3 . In other LeuT structures, tricyclic antidepressants (TCAs) were bound in this same extracellular vestibule above the substrate-bound S1 site 4,5 , again within a structure nearly identical to the original LeuT.
According to the first reported LeuT structure 1 (PDB 2A65), one leucine substrate is bound in an occluded, centrally located binding site, termed the primary substrate (S1) binding site, next to two Na + ions. Subsequent LeuT structures revealed other amino acid substrates in place of leucine in the S1 site, with an essentially identical protein structure 2 . Although density in an extracellular vestibule ~11 Å above the leucine-bound S1 site was originally interpreted as water molecules 2 (see Fig. S7 in ref. 2), this structure was refined to show a molecule of n-octyl-β-D-glucopyranoside (octylglucoside) detergent in this position (PDB 3F3E, with an all-Cα r.m.s. deviation of 0.17 against PDB 2A65) 2 , in agreement with another structure that resolved octylglucoside in this site (PDB 3GJC) 3 . In other LeuT structures, tricyclic antidepressants (TCAs) were bound in this same extracellular vestibule above the substrate-bound S1 site 4, 5 , again within a structure nearly identical to the original LeuT. In our studies of the molecular mechanism of Na + -coupled substrate transport, we identified a second high-affinity substrate binding site S2 in the extracellular vestibule, using computational molecular dynamics simulations in conjunction with radiotracer binding and flux experiments 6 . The position and functional role of the substrate in the S2 site led us to propose a mechanistic model of Na + -coupled symport in which intracellular release of Na + and S1 substrate is triggered by the binding of a second substrate molecule in the S2 site 6 . In functional studies, this mechanism was shown to be blocked if the S2 site is disrupted by mutations 6 or by its occupation with TCAs 5, 6 or octylglucoside 3 , the detergent used for all LeuT crystallization. The disruption of the S2 site by these means abolishes transport of alanine, a well-transported LeuT substrate, and eliminates the characteristic dynamics of the alanineinduced intracellular gating process we observed with single-molecule imaging 7 . A compelling feature of the dynamic model proposed from these studies, in which long range allosteric effects determine functional processes, is that it explains experimental evidence obtained for other transporters that are known to share the LeuT-like fold, even when details are different, such as for ApcT 8 , and that it agrees with data for the homologous eukaryotic NSSs for which structures are not yet available (for example, see refs. 9,10).
The role of two substrate binding sites in this model has been challenged by a recent study reporting on a variety of binding measurements that seemed to lead to the conclusion that LeuT has only a single high-affinity substrate site 11 . As described here, we have sought to eliminate the possibility that this discrepancy is due to methodological limitations. To this end, we conducted equilibrium dialysis studies to measure the molar Leu/LeuT ratio using LeuT-WT, and LeuT mutants with either an impaired S1 site (LeuT-F253A) 7, 12 or S2 site (LeuT-L400S) 3, 6, 7 . We found the stoichiometry of LeuT-WT to be 2, whereas disruption of either binding site led to a stoichiometry of 1, identical to our results using scintillation proximity analysis 6 . However, we now show that leucine binding in the S2 site can be impaired by the protein preparation procedures used for crystallography and for some functional studies, which explains the apparent discrepancy in reported stoichiometry. When these protein preparation procedures are used, the apparent stoichiometry is 1, and the functional mechanism that depends on the interplay between the substrate effects in the doubly occupied transporter is masked. 
RESULTS
LeuT has two high-affinity substrate binding sites Consistent with our previous findings, the equilibrium dialysis experiments conducted in order to determine the molar Leu/LeuT ratio showed that one molecule of LeuT-WT binds 1.94 ± 0.05 (n = 4) molecules of 3 H-Leu with a K d of 57.3 ± 5.8 nM (Fig. 1a) , whereas one molecule of LeuT-L400S or LeuT-F253A binds only 1.1 ± 0.04 (n = 2) or 1.01 ± 0.04 (n = 2) molecule of leucine, with a K d of 103.2 ± 12.2 nM or 110.2 ± 17.5 nM, respectively (Fig. 1b,c) . Notably, all three constructs show similar affinities for leucine, supporting our previous conclusion that the two binding sites have comparable high-affinity leucine binding 3, 6 . Furthermore, we observed inhibition of 3 H-Leu binding by clomipramine (CMI), a TCA that was shown to bind in the extracellular vestibule 4 and to inhibit about 50% of 3 H-Leu binding by LeuT-WT 6 , again in contrast to the study described in ref. 11 . Equilibrium dialysis showed, as our previous studies have, that 1 mM CMI inhibited 3 H-Leu binding by LeuT-WT to 45.2 ± 4.7% (n = 3) of binding in the absence of CMI. (Fig. 1d) , consistent with the notion that CMI blocks leucine binding to the S2 site, as would be expected based on its localization in the S2 site in the crystal structure 4, 5 . Moreover, CMI almost completely abolished the binding of leucine by the S1 site mutant LeuT-F253A (5.8% residual binding compared to that in the absence of CMI; n = 2) (Fig. 1d) that can bind leucine only in the S2 site 7, 12 . By contrast, 1 mM CMI did not affect 3 H-Leu binding by the S2 site mutant LeuT-L400S (95.6% residual binding compared to that in the absence of CMI; n = 2) (Fig. 1d) . The stark disagreement between the results of our equilibrium dialysis binding experiments and those reported by the study described in ref. 11 raised the question of what experimental conditions could lead to such contrasting findings about the behavior of these membrane protein systems.
The S2 site can be impaired by concentrating the protein All of our binding experiments described above were conducted with protein that was used after immobilized metal chelate affinity chromatography (IMAC). Unexpectedly, we found that concentrating LeuT-WT about ten-fold by centrifugal filtration reduced the Leu-to-LeuT binding stoichiometry from about 2 to 1 (Fig. 2a) . By contrast, the binding stoichiometry of the S2 site mutant LeuT-L400S remained ~1, regardless of whether or not the protein had been previously concentrated (Fig. 2b) , whereas binding to LeuT-F253A, in which the mutation eliminates binding to the S1 site, was almost abolished by concentrating the protein before the binding assay (Fig. 2c) . This behavior was observed when the binding was carried out by scintillation proximity assay (SPA) (Fig. 2a-c) or by equilibrium dialysis (Fig. 2d) . As only leucine binding in the S2 site was impaired by concentrating the protein, we conclude that concentrating LeuT can obscure the S2 site, mimicking the effect of the S2 site blocker CMI or the detergent octylglucoside 3 . Consistent with this inference, when previously concentrated LeuT-WT was used, addition of CMI had no appreciable effect on leucine-binding activity (Supplementary Fig. 1 ).
Detergent affects LeuT activity
Because the elucidation of functional mechanisms of this transporter, and indeed membrane proteins in general, is strongly dependent on the type of biochemical experiments represented here, it is essential to understand why concentrating the protein blocks leucine binding to the functionally important S2 site. We have previously shown that the detergent octylglucoside, like CMI, binds to the S2 site 3, 7 , and that competition for S2 binding blocks the dynamic cooperativity between substrates bound in the S2 and S1 sites 3, 7 that is required for the Na + -coupled symport model we proposed 6 . Therefore, we hypothesized that raising the concentration of n-dodecyl-β-d-maltopyranoside (DDM), in which the binding studies described here were conducted, might also impair binding to the S2 site. Indeed, concentrating LeuT by centrifugal filtration led to an essentially proportional increase in DDM concentration (Supplementary Fig. 2 ). The loss of leucine binding with increase in DDM concentration was found to be progressive ( Fig. 3a) but much slower than that produced by octylglucoside. Thus, addition of 1.17% octylglucoside rapidly reduced binding of 500 nM 3 H-Leu by LeuT-WT to about 50% of that observed in 0.1% DDM. The half-time of binding loss observed when increasing the DDM concentration in the assay buffer to 0.3% was ~250 h, with a stable plateau at half of the original binding. Further, consistent with our hypothesis that the S2 site is specifically impaired by detergent, leucine binding to the S2 site mutant LeuT-L400S was unaffected either by addition of octylglucoside 3 or by raising the DDM concentration to 0.3% (Fig. 3b) . By contrast, when binding is limited to the S2 site alone by the F253A mutation, octylglucoside or elevated DDM nearly eliminated leucine binding with half-time constants similar to those for WT (Fig. 3c) . All these data show that the increased concentration of DDM causes a specific, time-dependent elimination of leucine binding in the S2 site. Notably, another study 13 recently demonstrated that following an increase in the final concentration of DDM from ~0.05% to ~0.21%, 3 H-Leu binding to LeuT was reduced by about 50% over a period of 12 d. These authors attributed the loss of binding to instability and denaturation of LeuT in DDM, but we have found that leucine binding by LeuT is stable for at least several weeks in the presence of 0.1% DDM 3, 6 , suggesting that in the above study 13 , they were observing a slow loss of S2 binding induced by the increase in DDM concentration. Similarly, the study described in ref. 11 used protein that was concentrated by centrifugal filtration, apparently leading to loss of leucine binding to the S2 site.
The integrity of the S2 site can be preserved by immediate dilution of concentrated LeuT in 0.1% DDM-containing assay buffer 3 . However, when the protein was kept in 0.3% DDM in the absence of leucine and then was assayed in 0.1% DDM, LeuT-WT showed a rapid loss of 3 H-Leu binding, reaching 50% binding with a half-time of only ~0.4 h (Fig. 3d) . This is in contrast to the much slower loss of 3 H-Leu binding in 0.3% DDM observed in the presence of 500 nM leucine (Fig. 3a) , showing that the presence of leucine in the S2 site slows by nearly three orders of magnitude the loss of leucine binding to the S2 site caused by increasing the concentration of DDM. To determine the concentration dependence of the inhibitory effect of DDM on the 'unprotected' S2 site, we measured binding of 3 H-Leu by LeuT-WT that had been preincubated in the presence of increasing concentrations of DDM for 2 h. The threshold-like effect between 0.15% and 0.175% DDM (Supplementary Fig. 3) Na + -substrate symport requires S1 and S2 binding As expected, the elimination of the S2 site by elevated DDM affects the mechanistic picture of LeuT-mediated Na + -coupled transport. The interaction between substrate molecules bound simultaneously in the S1 and S2 sites was demonstrated previously by trapping 3 H-Leu in the S1 site, emptying the S2 site and then rebinding unlabeled leucine in the S2 site in the absence of Na + , which triggers the inward release of leucine from the S1 site (Fig. 4a) 3, 6 . LeuT-WT that was subjected to extended treatment with 0.3% DDM still trapped 3 H-Leu in the S1 site, but adding leucine in the absence of Na + failed to induce the release of 3 H-Leu from the S1 site (Fig. 4a) , consistent with the loss of leucine binding to the S2 site, where it must act as a symport effector to enable transport. Specific lipid requirements have been demonstrated before for transporters and channels 14, 15 . Because we found for LeuT that the increase in DDM concentration was accompanied by a reduction in the lipid/protein ratio (Supplementary Fig. 2) , we tested the addition of polar Escherichia coli lipids at a concentration typically used for subsequent reconstitution into proteoliposomes, but this failed to prevent or restore the loss of leucine binding to the S2 site observed in the presence of 0.3% DDM (Supplementary Fig. 4 ). The possibility of restoring the S2-related functional mechanism by reconstitution of concentrated LeuT into liposomes made of polar E. coli lipids was tested by adding Bio-Beads to remove the detergent [16] [17] [18] . Indeed, we found that reconstitution of LeuT-WT and LeuT-F253A into proteoliposomes restored S2 binding, as we observed essentially identical activity patterns for WT and the mutants regardless of whether we used nonconcentrated or concentrated material for the reconstitution (Fig. 4b) . Because serine substitution of leucine at position 400 abrogates binding to the S2 site, 3 H-Leu binding by LeuT-L400S was comparable in the detergent-solubilized form or when it was reconstituted into proteoliposomes, regardless of whether or not the material had been concentrated (Fig. 4b) . This is consistent with the notion that concentrating the protein affects the S2 site specifically. By contrast, restoration of the S2 site by reconstitution led to a binding stoichiometry for LeuT-WT that was twice that of LeuT-L400S, consistent with recovery of binding to the S2 site. Moreover, whereas binding to the S1-site mutant LeuT-253A was negligible after preincubation in 0.3% DDM, binding to the S2 site was restored after reconstitution. Not unexpectedly, the efficiency of reconstitution was not perfect, and we measured a stoichiometry of ~1.5 molecules of leucine per molecule of LeuT-WT (at 500 nM 3 H-Leu), whereas the variants with impaired S2 or S1 sites (LeuT-L400S and LeuT-F253A, respectively) bound ~0.8 molecules of leucine per LeuT after their reconstitution into proteoliposomes (Fig. 4b) . Further, consistent with the mechanistic proposal that intact S1 and S2 sites are required for Na + -coupled transport, reconstituted LeuT-WT mediated robust alanine uptake activity, regardless of whether concentrated or nonconcentrated material was used (Fig. 4c) . By contrast, loss of a functional S2 or S1 site (by mutation of L400S or F253A, respectively), resulted in an impaired transport phenotype indistinguishable from that observed in control liposomes without LeuT (Fig. 4c) .
DISCUSSION
The breakthrough structural context from the first high-resolution structure of LeuT 1 informed computational studies combined with binding and flux experiments 6 that revealed the second high-affinity substrate (S2) binding site in an extracellular vestibule also shown to bind TCAs 4, 5 . We proposed a model of Na + -coupled symport in which intracellular release of Na + and S1 substrate is triggered by the binding of a second substrate in the S2 site. The transport mechanism was shown to be blocked if the S2 site is disrupted by mutations 6 or by its occupation with TCAs 4,5 or octylglucoside 3 . Single-molecule imaging also demonstrated that disrupting the S2 site prevents not only transport but also the enhancement of intracellular gate dynamics induced by a welltransported substrate, alanine 7 . Thus, substrate binding in the S2 site acts cooperatively with the S1 site to control the Na + -coupled symport mechanism through intracellular gating more than 30 Å away.
We show here that the S2 site can be blocked during preparation of detergent-solubilized LeuT, thereby obscuring Na + -coupled symport. This brings to light the need for appropriate attention to the experimental environment when delineating the properties and mechanistic features of membrane proteins. The S1 or S2 site mutants studied here (F253A and L400S) have an 'all-or-nothing' effect on leucine binding to the targeted site, presumably because the mutation has sufficiently impaired binding affinity to render leucine binding to the targeted site undetectable under our experimental conditions. In a search for an intermediate phenotype, we discovered that the construct with a cysteine instead of Asp404 in the S2 site 6 demonstrates the complex allosteric connection between the two binding sites. A mutagenesis study of the aligned glutamate in SERT has implicated it in forming part of an external gate 19 . Leucine binding to LeuT-D404C in 0.1% DDM (Supplementary Fig. 5a ) follows a complex binding isotherm, best fit by a two-site model with one high-affinity site of 34.1 ± 5.4 nM and a stoichiometry of 1 (constrained), and a second, lower affinity site with an affinity of 238.2 ± 121 nM and a stoichiometry of 0.47 ± 0.07. Given the position of the mutation in the S2 site, these data provide evidence for partially disrupted binding of leucine in the S2 site. By contrast, preincubation of the purified protein in 0.3% DDM yielded a saturation curve that was well fit with a single-site equation, with a Leu-to-LeuT stoichiometry of 1.01 ± 0.05 and a K d of 76.8 ± 10.8 nM (Supplementary Fig. 5b) , consistent with binding to the S1 site alone. Thus, the effect of 0.3% DDM is to completely eliminate binding to the S2 site, leaving normal residual S1 binding. That impaired binding in the S2 site of the D404C mutant is accompanied by a partially uncoupled interaction between the S1 and S2 sites in D404C is supported by the impaired transport phenotype of this mutant, which is only 15-20% of that observed for LeuT-WT (Supplementary Fig. 5c ). By contrast, as discussed above, transport is completely disrupted in LeuT-F253A and LeuT-L400S (Fig. 4c) , which have lost the ability to bind substrate in the S1 or S2 sites, respectively (Fig. 4b) .The structural underpinning of the altered leucine binding and transport behavior of LeuT-D404C may relate to the observation that Asp404 forms salt-bridge-cation-π interactions with Arg30 and Phe253, the latter functioning as the 'gate' to the S1 site. Asp404 also forms a hydrogen bond with Tyr107, at the bottom of the S2 site. From our in silico mutagenesis (with alchemical free energy perturbation-molecular dynamics (FEP-MD)), we find that the mutation of Asp404 and the associated loss of the Asp404-Tyr107 hydrogen bond alter the dynamics of the aromatic cluster between the S1 and S2 sites 12 and thereby disrupt efficient formation of the S2 site.
The findings described here highlight a notable and unexpected example of the profound effects that common protein preparation procedures can have on the observation and measurement of the properties and mechanism of LeuT function. Indeed, here they are shown to obscure the nature and extent of ligand binding and the dynamic interactions between the S1 and S2 sites of LeuT. These findings reaffirm our previous observations that Na + -coupled substrate transport requires the high-affinity binding of substrate in npg a r t i c l e s both the S1 and S2 sites of LeuT to produce the long-range conformational gating dynamics suggested from the computational simulations and measured in the EPR and smFRET experiments 6, 7, 12 . It is clear, however, that the preparation procedure can impair leucine binding to the S2 site and thus impair the allosteric transport mechanism. Because the communication between the sites in the doubly occupied transporter is essential, the mechanism will not work when one site is occluded by experimental conditions. Given the widely recognized role of allosteric mechanisms in the function of membrane proteins [20] [21] [22] [23] [24] and the great interest in biophysical experimentation to reveal functional mechanisms, our results reveal important considerations regarding the effects that detergent and lipids can have on our ability to make mechanistic inferences. We show that the mechanistic investigation of membrane proteins that are likely to use the same type of mechanisms, in which long range allosteric effects determine functional processes, requires specific attention to the effects of preparations that can markedly alter protein function and lead to misinterpretation of structural data. It is thus imperative to develop new methods and/or combine existing ones to delineate the critical mechanistic features of these protein systems, with appropriate attention to specific requirements for the properties of the environment in which these systems are studied, both experimentally and computationally.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. 
ONLINE METHODS
Protein expression, purification and preparation for functional assays. LeuT-WT, LeuT-L400S or LeuT-F253A were produced in E. coli C41(DE3) harboring pQO18 (or derivatives thereof carrying given mutations) [25] [26] [27] . LeuT variants were purified by immobilized metal (Ni 2+ ) affinity chromatography as described 25 , and-if indicated-the protein was concentrated by centrifugal filtration using Vivaspin 6, MWCO 50,000, devices. Protein was assayed using the amido black method 28 , which was validated for LeuT quantitation using quantitative amino acid analysis (conducted at the Keck Biotechnology Resource Laboratory at Yale University).
Binding studies. Equilibrium dialysis was carried out with the HTD96b dialysis 96-well apparatus and 12,000-14,000 MWCO membranes in 150 mM Tris-Mes, pH 7.5, 50 mM NaCl, 1 mM TCEP, 0.1% (w/v) DDM for 16 h at 22 °C with 4 pmol of the indicated LeuT variant. l- [4, H]leucine (Moravek; used at 15 Ci mmol −1 ) was used at the indicated concentrations. Twenty microliter samples were taken from each dialysis compartment separated by the membrane (total volume per compartment was 50 µL) and incubated with a scintillation cocktail for 24 h before counting d.p.m. using a photomultiplier tube. To capture LeuT bound to the dialysis membrane, the exposed membrane section was excised and measured by scintillation counting. Nonspecific binding of 3 H-Leu to the membrane was determined by doing the assay in the absence of LeuT, and data were corrected accordingly. The d.p.m. values were converted to pmol, using known amounts of 3 H-Leu.
SPA-based binding of 3 H-leucine (140 Ci mmol −1 ; Moravek) to purified LeuT variants was done as described 25 with 0.415 pmol of purified protein per assay in a buffer composed of 150 mM Tris-Mes, pH 7.5, 50 mM NaCl, 1 mM TCEP, 0.1% (w/v) DDM and 20% (v/v) glycerol.
Transport and binding in proteoliposomes.
Purified LeuT variants were reconstituted at a 1:150 (w/w) ratio in preformed liposomes made of E. coli polar lipid extract (Avanti) that were destabilized with 0.11% (w/v) Triton X-100 as described 27 . Detergent was removed by stepwise addition of a total of 240 mg ml −1 Bio-Beads SM-2 (Bio-Rad), and the proteoliposomes (or control liposomes lacking LeuT) were collected by ultracentrifugation at 320,000g for 45 min, resuspended (to ~100 mg lipids ml −1 ) in 100 mM potassium phosphate, pH 6.5, and 1 mM TCEP and stored in liquid N 2 . Prior to uptake measurements, the proteoliposomes were thawed at 23 °C and extruded through a 400-nm filter (Avanti). The accumulation of 1 µM 3 H-Ala (49.4 Ci mmol −1 ; Moravek) was measured for the indicated periods of time at 22 °C in assay buffer composed of 50 mM Tris-Mes, pH 8.5, and 50 mM NaCl. Binding of 3 H-Leu to LeuT proteoliposomes was assayed by dissipating the electrochemical NaCl gradient with 25 µg gramicidin ml −1 for 5 min before the start of the 4-h reaction. Uptake and binding reactions were stopped by quenching the samples with an ice-cold assay buffer followed by rapid filtration through 0.22-µm nitrocellulose filters (Millipore) and scintillation counting. C.p.m. were converted into pmol using known amounts of 3 H-Leu. To obtain molar Leu/LeuT ratios, the same batches of proteoliposomes that were used for the uptake and binding experiment were measured using protein assays 28 .
Determination of lipid and detergent. The amount of phospholipids and saccharidebased detergents was assayed using established analytical methods 29, 30 .
Data analysis. All experiments were repeated at least in duplicate. Figures represent typical experiments, and-unless otherwise noted-data points represent the mean of a triplicate determination (n = 3) ± s.e.m. Data fits of kinetic analyses were carried out using nonlinear regression algorithms in Sigmaplot (SPSS) or Prism (GraphPad), and errors represent standard error of the fit.
